Back to Search
ANTHONY AVALLONE MD
MD
Urology Physician
NPI: 1659328540Individual
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
ME121181(FL)093641(OH)MD-46514(IA)
Research & Publications (20)
Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.
PMID 17581300·Anticancer Drugs·2007
8-other
Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer: a randomized phase II SICOG trial.
PMID 19545929·Lung Cancer·2010
3-trial
Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed.
PMID 19270508·Cancer Biol Ther·2009
8-other
Role of oxaliplatin in the treatment of colorectal cancer.
PMID 19436599·Ther Clin Risk Manag·2009
8-other
Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence.
PMID 18457461·Drugs·2008
6-review
Comparison of the safety and efficacy of paclitaxel plus gemcitabine combination in young and elderly patients with locally advanced or metastatic non-small cell lung cancer. A retrospective analysis of the Southern Italy Cooperative Oncology Group trials.
PMID 17702595·Crit Rev Oncol Hematol·2008
4-observational
Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial.
PMID 17298853·Lung Cancer·2007
3-trial
Squamous cell carcinoma of the scrotum in a radiation technologist and the use of sentinel lymph node biopsy in recurrent disease.
PMID 17375795·Am Surg·2007
5-case
18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.
PMID 16883000·J Nucl Med·2006
3-trial
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
PMID 16428508·Clin Cancer Res·2006
4-observational
Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study.
PMID 16736001·Br J Cancer·2006
3-trial
Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
PMID 12599217·J Cell Physiol·2003
8-other
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases.
PMID 14504054·Ann Oncol·2003
8-other
Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies.
PMID 12453855·Ann Oncol·2002
3-trial
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients.
PMID 12085178·Br J Cancer·2002
3-trial
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.
PMID 12196371·Ann Oncol·2002
4-observational
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
PMID 12381902·Oncology·2002
3-trial
Phase I study of mitoxantrone, raltitrexed, levofolinic acid and 5-fluorouracil in advanced solid tumours.
PMID 11269736·Cancer Chemother Pharmacol·2001
3-trial
Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy.
PMID 11459994·Anticancer Drugs·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5950 UNIVERSITY AVE STE 341
WEST DES MOINES, IA 50266 - Phone
- (515) 875-9800
Quick Facts
- NPI
- 1659328540
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile